Contemporary approaches to genetic influences on hypertension

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 1, 2011, Pages 23-30

  Fung, Maple M ^a   Zhang, Kuixing ^a   Zhang, Lian ^a   Rao, Fangwen ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genetics; Genome wide; Hypertension; Proteomics; Systems biology

Indexed keywords

DNA; RNA;

ARTICLE; ASSOCIATION; BACTERIAL GENE; BLOOD PRESSURE; DISEASE ASSOCIATION; ENVIRONMENT; EPISTASIS; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HUMAN; HYPERTENSION; KNOWLEDGE; LONG TERM CARE; MEIOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEOMICS; RESEARCH; SYSTEMS BIOLOGY; TECHNOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; EPISTASIS, GENETIC; GENE DOSAGE; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; MICRORNAS; PHENOTYPE; PROTEOMICS; SEQUENCE ANALYSIS, DNA; SYSTEMS BIOLOGY;

EID: 79851507538     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283406ecf     Document Type: Article

References (66)

1. Kupper N, Willemsen G, Riese H, et al. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 2005; 45:80-85. (Pubitemid 40066418)
2. Charchar F, Zimmerli L, Tomaszewski M. The pressure of finding human hypertension genes: new tools, old dilemmas. J Hum Hypertens 2008; 22:821-828.
3. Gerbase-DeLima M, DeLima JJ, Persoli LB, et al. Essential hypertension and histocompatibility antigens: a linkage study. Hypertension 1989; 14:604-609. (Pubitemid 20020819)
4. O'Connor DT, Zhu G, Rao F, et al. Heritability and genome-wide linkage in US and Australian twins identify novel genomic regions controlling chromogranin A: implications for secretion and blood pressure. Circulation 2008; 118:247-257.
5. Hoehe MR, Plaetke R, Otterud B, et al. Genetic linkage of the human gene for phenylethanolamine N-methyltransferase (PNMT), the adrenaline-synthesizing enzyme, to DNA markers on chromosome 17q21 -q22. Hum Mol Genet 1992; 1:175-178.
6. Zhang K, Weder AB, Eskin E, O'Connor DT. Genome-wide case/control studies in hypertension: only the 'tip of the iceberg'. J Hypertens 2010; 28:1115-1123.
7. Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 2008; 10:560-574.
8. Zhu X, Chang YP, Yan D, et al. Associations between hypertension and genes in the renin -angiotensin system. Hypertension 2003; 41:1027-1034. (Pubitemid 36548599)
9. Wu X, Luke A, Rieder M, et al. An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertens 2003; 21:1847-1852. (Pubitemid 37304039)
10. Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:1285-1287. (Pubitemid 24087185)
11. Chen Y, Rao F, Rodriguez-Flores JL, et al. Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int 2008; 74:115-125. (Pubitemid 351841890)
12. Rao F, Zhang L, Wessel J, et al. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 2007; 116:993-1006. (Pubitemid 47329564)
13. Wen G, Wessel J, Zhou W, et al. An ancestral variant of secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. Hum Mol Genet 2007; 16:1752-1764. (Pubitemid 47241834)
14. Zhang K, Zhang L, Rao R, et al. Human tyrosine hydroxylase natural genetic variation: delineation of functional transcriptional control motifs disrupted in the proximal promoter. Circ Cardiovasc Genet 2010; 3:187-198.
15. Zhang L, Rao F, Wessel J, et al. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genom 2004; 19:277-291. (Pubitemid 40039934)
16. Nielsen SJ, Jeppesen J, Torp-Pedersen C, et al. Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study. Am J Hypertens 2010 [Epub ahead of print].
17. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008; 40:695-701. (Pubitemid 351748875)
18. Ji W, Foo JN, O'Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592-599. (Pubitemid 351601207)
19. Wellcome Trust Case Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
20. Levy D, Larson MG, Benjamin EJ, et al. Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007; 8 (Suppl 1):S3.
21. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41:677-687.
22. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41:666-676.
23. Liang M, Liu Y, Mladinov D, et al. MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol 2009; 297:F553-F558.
24. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 2007; 81:405-413. (Pubitemid 47236088)
25. Palatini P, Ceolotto G, Dorigatti F, et al. Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am J Hypertens 2009; 22:208-214.
26. Wang L, Rao F, Zhang K, et al. Neuropeptide Y(1) receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol 2009; 54:944-954.
27. Chen Y, Rao F, Rodriguez-Flores JL, et al. Naturally occurring human genetic variation in the 3'-untranslated region ofthe secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion. J Am Coll Cardiol 2008; 52:1468-1481.
28. Glinsky GV. An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle 2008; 7:2570-2583.
29. Kenyon GL, DeMarini DM, Fuchs E, et al. Defining the mandate of proteomics in the postgenomics era: workshop report. Mol Cell Proteomics 2002; 1:763-780.
30. Bian YL, Qi YX, Yan ZQ, et al. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor. Eur J Cell Biol 2008; 87:101-110.
31. Delbosc S, Haloui M, Louedec L, et al. Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med 2008; 14:383-394.
32. Junhong W, Jing Y, Jizheng M, et al. Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats. Int J Cardiol 2008; 127:198-207. (Pubitemid 351787791)
33. Gallego-Delgado J, Lazaro A, Osende JI, et al. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. J Am Soc Nephrol 2006; 17:S159-S164. (Pubitemid 44865242)
34. Gardner TS, di Bernardo D, Lorenz D, Collins JJ. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 2003; 301:102-105. (Pubitemid 36801571)
35. Jirout ML, Friese RS, Mahapatra NR, et al. Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat. Hum Mol Genet 2010; 19:2567-2580.
36. Fries RS, Mahboubi P, Mahapatra NR, et al. Neuroendocrine transcriptome in genetic hypertension: multiple changes in diverse adrenal physiological systems. Hypertension 2004; 43:1301-1311. (Pubitemid 38691754)
37. Friese RS, Mahboubi P, Mahapatra NR, et al. Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension. Am J Hypertens 2005; 18:633-652. (Pubitemid 40692431)
38. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7:829-840.
39. Nadeau JH, Singer JB, Matin A, Lander ES. Analysing complex genetic traits with chromosome substitution strains. Nat Genet 2000; 24:221-225. (Pubitemid 30132188)
40. Hubner N, Wallace CA, Zimdahl H, et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 2005; 37:243-253. (Pubitemid 41716251)
41. Atanur SS, Birol I, Guryev V, et al. The genome sequence of the spontaneously hypertensive rat: analysis and functional significance. Genome Res 2010; 20:791-803.
42. Charchar FJ, Kaiser M, Bingham AJ, et al. Whole genome survey of copy number variation in the spontaneously hypertensive rat: relationship to quantitative trait loci, gene expression, and blood pressure. Hypertension 2010; 55:1231-1238.
43. Geurts AM, Cost GJ, Freyvert Y, et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 2009; 325:433.
44. Chen D, La Greca L, Head GA, et al. The day-night difference of blood pressure is increased in AT(1A)-receptor knockout mice on a high-sodium diet. Am J Hypertens 2010; 23:481-487.
45. Kisanuki YY, Emoto N, Ohuchi T, et al. Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 2010; 56:121-128.
46. Vaingankar SM, Li Y, Biswas N, et al. Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses. J Hypertens 2010; 28:817-825.
47. Friese RS, Gayen JR, Mahapatra NR, et al. Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification. Physiol Genom 2010; 40:195-207.
48. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913. (Pubitemid 35472129)
49. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
50. O'Connor DT, Insel PA, Ziegler MG, et al. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2000; 2:16-22.
51. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34:724-728. (Pubitemid 29501288)
52. De Lima JJ, Dias MM, Bernardes-Silva H, Bellotti G. Pressor response to norepinephrine in essential hypertension. A study in families. Hypertension 1990; 15:1137-1139.
53. Bianchetti MG, Beretta-Piccoli C, Weidmann P, Ferrier C. Blood pressure control in normotensive members of hypertensive families. Kidney Int 1986; 29:882-888. (Pubitemid 16094017)
54. Ferrier C, Cox H, Esler M. Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci (Lond) 1993; 84:225-230. (Pubitemid 23053230)
55. Dao TT, Kailasam MT, Parmer RJ, et al. Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. J Hypertens 1998; 16:779-792. (Pubitemid 28247961)
56. O'Connor DT, Kailasam MT, Kennedy BP, et al. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 2002; 20:1335-1345. (Pubitemid 34925678)
57. Moreno C, Kaldunski ML, Wang T, et al. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genom 2007; 31:228-235. (Pubitemid 350014400)
58. Cicila GT, Morgan EE, Lee SJ, et al. Epistatic genetic determinants of blood pressure and mortality in a salt-sensitive hypertension model. Hypertension 2009; 53:725-732.
59. Wessel J, Moratorio G, Rao F, et al. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. J Hypertens 2007; 25:329-343. (Pubitemid 46071931)
60. Feero WG, Guttmacher AE, Collins FS. Genomic medicine: an updated primer. N Engl J Med 2010; 362:2001-2011.
61. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447:433-440. (Pubitemid 46816750)
62. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 2010; 464:1351-1356.
63. Beitelshees AL, Gong Y, Wang D, et al. KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenet Genom 2007; 17:719-729. (Pubitemid 47263067)
64. Bhatnagar V, O'Connor DT, Schork NJ, et al. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens 2007; 25:2082-2092. (Pubitemid 47476305)
65. Metzker ML. Sequencing technologies: the next generation. Nat Rev Genet 2010; 11:31-46.
66. Chen Y, Wen G, Rao F, et al. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J Hypertens 2010; 28:76-86.